Abstract

Scopolamine Hydrobromide -.4-mg/mL Injection

Author(s): Allen Loyd V Jr

Issue: May/Jun 2015 - Volume 19, Number 3

Page(s): 247

Download in electronic PDF format for $75
  • Scopolamine Hydrobromide -.4-mg/mL Injection Page 1

Abstract

A formulation for preparing Scopolamine Hydrobromide -.4-mg/mL Injection. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • scopolamine hydrobromide
  • compounded sterile preparations
  • aseptic compounding
  • nausea
  • vomiting
  • motion sickness
  • postsurgical emesis
  • antiemetic

Related Categories

  • FORMULATIONS
  • GASTROENTEROLOGY
  • STERILE PREPARATIONS
  • NEUROLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
May/Jun 2015
Pg. 247
Scopolamine Hydrobromide -.4-mg/mL Injection
Author(s): Allen Loyd V Jr
Jul/Aug 2016
Pg. 326
Scopolamine Hydrobromide 0.25% Ophthalmic Solution
Author(s): Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Sep/Oct 2009
Pg. 438-439
Chemical Stability of Scopolamine Hydrobromide Nasal Solution
Author(s): Gupta Vishnu D
May/Jun 2004
Pg. 185
Scopolamine Hydrobromide 0.25-mg/0.1-mL Topical Gel
Author(s): Hinkle Amanda R, Newton Gail D
Jan/Feb 1997
Pg. 37
Scopolamine Hydrobromide 0.4-mg/0.1-mL Nasal Solution
Author(s): Allen Loyd V Jr
Jan/Feb 1997
Pg. 38
Scopolamine Hydrobromide 0.25-mg/0.1-mL Topical Gel
Author(s): Allen Loyd V Jr
May/Jun 2000
Pg. 169
Scopolamine Hydrobromide 0.4-mg per 0.1-mL Nasal Solution
Author(s): Allen Loyd V Jr
Jul/Aug 2004
Pg. 269-274
Current Topical Treatments in Wound Healing - Part 1
Author(s): Helmke Christopher D
Jan/Feb 2004
Pg. 58
Scopolamine Hydrobromide 0.2% Nasal Spray
Author(s): Allen Loyd V Jr
Jan/Feb 2014
Pg. 6-12
The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013
Author(s): Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
Sep/Oct 2018
Pg. 387-398
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations
Author(s): Ashe Krystina, Baskett Dustin
Mar/Apr 2013
Pg. 113-123
Nausea and Vomiting in Pregnancy: A Review of the Pathology and Compounding Opportunities
Author(s): Zur Eyal
Mar/Apr 2004
Pg. 89-94
Overview of Chapter <797> "Pharmaceutical Compounding - Sterile Preparations": The Potential Impact for Compounding Pharmacists
Author(s): Rahe Hank
Jul/Aug 2000
Pg. 250-251
Nausea and Vomiting in Hospice Patients
Author(s): Boomsma Diane
May/Jun 2019
Pg. 221-228
Basics of Sterile Compounding: Vehicles Used in Sterile Compounding
Author(s): Allen Loyd V Jr
Sep/Oct 2016
Pg. 399-404
Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions
Author(s): Allen Loyd V Jr
May/Jun 2022
Pg. 248-254
Physical and Chemical Stability of Pharmaceutical Preparation of Bumetanide and Scopolamine
Author(s): Catry Emilie, Colsoul Marie-Louise, Closset Melanie, Hubert Justine, Soumoy Laura, Bihin Benoit, Thiry Emmanuell, Jamart Jacques, Hecq Jean-Daniel, Galanti Laurence
Jan/Feb 2022
Pg. 41-49
Sterile Basics: Compounding Sterile Preparations with Cyclodextrins
Author(s): Allen Loyd V Jr